Medicamen enters into domestic pharma

Published On 2022-10-06 11:30 GMT   |   Update On 2022-10-06 11:30 GMT

Mumbai: Pharma Major- Medicamen Biotech Ltd is foraying into Domestic Business with its subsidiary Medicamen Life Sciences Pvt Ltd.

While issuing the press release, Medicamen group chairman Mr. Rahul Bishnoi told "The Vision of the Company is to become a most admired Pharmaceutical organization by offering research & data backed, affordable & quality medicines for Indian population and to start with, the company has entered cardio-vascular & Diabetes (CVD) Business, which contributes annual revenue of more than Rs.50000 Crore to IPM with a CAGR of 11%".

Kamal Pahwa, a Pharma Veteran with 32 Year of Experience in CVD business and Pramod Sharma of Neelkanth Drugs Pvt Ltd, a distribution network in India has joined hands with Medicamen to launch this very Ambitious venture, said Mr. Bishnoi. Medicamen Biotech Ltd established in 1996, till now has been focusing on international business. It has recently commenced it's the state of art oncology plant at Haridwar which is meant for regulated market like US and Europe. Medicamen earlier this year has launched its high-quality oncology products in domestic market.

Advertisement

Read also: Roche unveils SARS-CoV-2 Rapid Antibody Test 2.




Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News